UCB licenses AI technology to ImageBiopsy Lab

By AuntMinnieEurope.com staff writers

October 28, 2021 -- UCB Pharma will license its artificial intelligence (AI) technology, which is designed to improve osteoporosis identification, to ImageBiopsy Lab, the Vienna-based company.

ImageBiopsy Lab, the winner of the 2021 Best New Vendor in the EuroMinnies awards scheme, plans to develop and launch an AI-based fracture identification tool based on UCB's BoneBot technology. BoneBot uses artificial intelligence to detect the presence of asymptomatic fractures in the spine.

Furthermore, UCB's BoneBot technology will be integrated with ImageBiopsy Lab's ZOO MSK platform and be delivered to hospitals to help to increase the reporting of spinal fractures.

Copyright © 2021 AuntMinnieEurope.com
Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking